Heraeus builds additional production line for pharmaceutical ingredients used in cancer therapy and solidifies world market leadership

Always in Motion - Expanding capacities for cancer therapy

Heraeus Pharmaceutical Ingredients is expanding its production capacities for Platinum-based Highly Potent Active Pharmaceutical Ingredients (Pt hAPIs). The expansion is Heraeus’ response to increasing global demands for these products in cancer treatment.

Carboplatin

Cancer cases are globally on the rise, causing an increasing demand for their treatment. As a response, Heraeus Pharmaceutical Ingredients expanses its production capacities for Platinum-based Highly Potent Active Pharmaceutical Ingredients (Pt hAPIs).

Construction of the new production line is already under way at the company’s headquarters in Hanau, Germany. With the multi-million Euro investment, Heraeus reinforces its worldwide market leadership position in this field, underscoring the company’s long tradition in top-quality precious metal technologies. The new expansion will further increase the company's market share.

to top